2.30
2.30 (0%)
As of Apr 25, 2025
Heron Therapeutics, Inc. [HRTX]
Source:
Company Overview
Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard of care for acute care and oncology patients.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | 8582514400 |
| Industry | manufacturing |
| CEO | Craig Collard |
| Website | www.herontx.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $144.3 |
| Operating Profit | $-11.5 |
| Net Income | $-13.6 |
| Net Cash | $-2.9 |
Profit Ratios
| Gross Margin | $105.6 |
| Operating Margin | -8 |
| Profit as % of Revenues | -777.9% |
| Profit as % of Assets | -6% |
| Profit as % of Stockholder Equity | 40.4% |
Management Effectiveness
| Return on Equity | 40.4% |
| Return on Assets | -5.8% |
| Turnover Ratio | 63.3% |
| EBITA | $-11.5 |
Balance Sheet and Cash Flow Measures
| Total Assets | $233.1 |
| Total Liabilities | $266.8 |
| Operating Cash Flow | $-22.5 |
| Investing Cash Flow | $18.7 |
| Financing Cash Flow | $0.9 |
